These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases]. Karateev AE, Nasonova VA, Murav'ev IuV. Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549 [Abstract] [Full Text] [Related]
9. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients. Hisamuddin K, Mowat NA, Phull PS. Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381 [Abstract] [Full Text] [Related]
10. Management of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs during the therapy of rheumatic diseases. The rheumatologist's perspective. Robinson DR. Am J Med; 1988 Feb 22; 84(2A):1-4. PubMed ID: 3126654 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients. Stupnicki T, Dietrich K, González-Carro P, Straszak A, Terjung A, Thomas KB, Lühmann R, Fischer R. Digestion; 2003 Feb 22; 68(4):198-208. PubMed ID: 14707396 [Abstract] [Full Text] [Related]
13. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. Cryer B, Kimmey MB. Am J Med; 1998 Jul 27; 105(1B):20S-30S. PubMed ID: 9715831 [Abstract] [Full Text] [Related]
17. Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Janssen M, Dijkmans BA, van der Sluys FA, van der Wielen JG, Havenga K, Vandenbroucke JP, Lamers CB, Zwinderman AH, Cats A. Br J Rheumatol; 1992 Nov 27; 31(11):747-52. PubMed ID: 1450796 [Abstract] [Full Text] [Related]
18. [Upper gastrointestinal tract lesions in rheumatoid arthritis]. Kikuchi M, Sato T, Nakano M, Ozawa T, Yoshida K, Takahashi C, Nakazono K, Murasawa A, Arakawa M. Ryumachi; 1991 Aug 27; 31(4):374-80. PubMed ID: 1948453 [Abstract] [Full Text] [Related]
19. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Brogden RN, Heel RC, Speight TM, Avery GS. Drugs; 1978 Aug 27; 16(2):97-114. PubMed ID: 352667 [No Abstract] [Full Text] [Related]
20. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment]. Martín de Argila C, Moreira V, Gisbert JP. An Med Interna; 1995 Feb 27; 12(2):85-96. PubMed ID: 7749017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]